BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Immune Response BioPharma  



     
Phone: Fax:


SEARCH JOBS










 Company News
Immune Response BioPharma Announces FDA BLA Fee Waiver Granted Clears Path For REMUNE Approval 4/2/2014 9:14:46 AM    More...
Immune Response BioPharma Announces NeuroVax Granted Fast Track FDA Designation For SPMS 3/21/2014 2:30:39 PM    More...
Immune Response BioPharma Posts 2nd Half & Full Year 2013 Results 2/24/2014 9:18:40 AM    More...
Immune Response BioPharma Announces REMUNE Granted Orphan Designation For Pediatric HIV/AIDS 2/18/2014 9:07:48 AM    More...
Immune Response BioPharma Announces NeuroVax Granted Orphan Designation For Pediatric MS 2/10/2014 9:17:16 AM    More...
Immune Response BioPharma Sets U.S. REMUNE Pricing Range $75-250 Per Dose 12/27/2013 8:02:18 AM    More...
Immune Response BioPharma To Develop Annual HIV Vaccine RemuneVax Based On Current HIV Strain 12/23/2013 10:36:05 AM    More...
Immune Response BioPharma To File Remune BLA With FDA By March 1st 2014 Submits Fee Waiver Request 12/3/2013 8:32:16 AM    More...
Immune Response BioPharma To Keep U.S. NeuroVax Rights For MS Expects Phase IIb Enrollment Q2 2015 11/25/2013 11:10:53 AM    More...
Immune Response BioPharma to Seek Fast Track & Orphan Designation of NeuroVax for SPMS 9/4/2013 9:11:01 AM    More...
123456